Quick Answer
Quoin Pharmaceuticals, Ltd. reported Stockholders Equity of $13.12 million for fiscal year 2025.
Quoin Pharmaceuticals, Ltd. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $13.12M | +42.5% |
| 2024 | $9.20M | +62.5% |
| 2023 | $5.66M | -23.5% |
| 2022 | $7.41M | +1027.3% |
| 2021 | $657.0K | +109.9% |
| 2020 | -$6.61M | -46.4% |
| 2019 | -$4.51M | -52.9% |
| 2018 | -$2.95M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.21M | -122.3% | -147.6% |
| June 30, 2025 | $2.55M | -65.9% | -56.9% |
| March 31, 2025 | $5.93M | -35.1% | -35.6% |
| December 31, 2024 | $9.20M | +62.5% | +69.2% |
| September 30, 2024 | $5.44M | -26.6% | -27.2% |
| June 30, 2024 | $7.48M | -17.6% | -18.1% |
| March 31, 2024 | $9.13M | -16.4% | +61.1% |
| December 31, 2023 | $5.66M | -23.5% | -23.6% |
- Quoin Pharmaceuticals, Ltd. showed an increase of +42.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Quoin Pharmaceuticals, Ltd.’s stockholders equity has grown by 544.5% (from -$2.95 million to $13.12 million).
- The most recent figure is from Quoin Pharmaceuticals, Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: